Clinical and laboratory characteristics of infectious mononucleosis by Epstein-Barr virus in Mexican children

BMC Research Notes

Hugo Juárez Olguín¹  Georgina Piña Ruiz²  Victor Antonio Monroy Colín²  Napoleón González Saldaña² 

[1] Department of Pharmacology, Faculty of Medicine, National Autonomous University of Mexico, Mexico City, 04510, Mexico;Department of Infectious Diseases, National Institute of Pediatrics, Avenida Insurgentes Sur 3700-C, Mexico City, 04530, Mexico

关键词: Pediatric infections;    Mononucleosis;    Epstein-Barr virus;   

Others  :  1166131
DOI  :  10.1186/1756-0500-5-361

 received in 2012-03-21, accepted in 2012-06-28,  发布年份 2012

【 摘 要 】

Background

Infectious mononucleosis (IM) or Mononucleosis syndrome is caused by an acute infection of Epstein-Barr virus. In Latin American countries, there are little information pertaining to the clinical manifestations and complications of this disease. For this reason, the purpose of this work was to describe the clinical and laboratory characteristics of infection by Epstein-Barr virus in Mexican children with infectious mononucleosis.

Methods

A descriptive study was carried out by reviewing the clinical files of patients less than 18 years old with clinical and serological diagnosis of IM by Epstein-Barr virus from November, 1970 to July, 2011 in a third level pediatric hospital in Mexico City.

Results

One hundred and sixty three cases of IM were found. The most frequent clinical signs were lymphadenopathy (89.5%), fever (79.7%), general body pain (69.3%), pharyngitis (55.2%), hepatomegaly (47.2%). The laboratory findings were lymphocytosis (41.7%), atypic lymphocytes (24.5%), and increased transaminases (30.9%), there were no rupture of the spleen and no deaths among the 163 cases.

Conclusions

Our results revealed that IM appeared in earlier ages compared with that reported in industrialized countries, where adolescents are the most affected group. Also, the order and frequency of the clinical manifestations were different in our country than in industrialized ones.

【 授权许可】

   
2012 González Saldaña et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Balfour HH, et al.: A prospective clinical study of Epstein-Barr virus and host interactions during acute infectious mononucleosis. J Infec Dis 2005, 192:1505-1512.
• [2]Ebell M: Epstein-Barr virus infectious mononucleosis. Am Fam Phys 2004, 70:1279-1290.
• [3]Lara-Vega HP: Mononucleosis infecciosa. Revista Medica de Costa Rica 2009, 587:73-77.
• [4]Crawford DH, et al.: A cohort study among university students: identification of risk factors for Epstein-Barr virus seroconversion and infectious mononucleosis. Clin Infec Dis J 2006, 43:276-282.
• [5]Kutok JL, Wang F: Spectrum of Epstein-Barr virus associated diseases. Ann Rev Pathol Mechanism Dis 2006, 1:375-404.
• [6]Luzuriaga K, Sullivan JL: Infectious mononucleosis. New Eng J Med 2010, 362:1993-2000.
• [7]Fica A: Síndrome de mononucleosis infecciosa en pacientes adolescentes y adultos. Rev Chilena Infectol 2003, 20:235-242.
• [8]Hoagland RJ: The clinical manifestations of infectious mononucleosis: a report of two hundred cases. Am J Med Sci 1960, 240:55-63.
• [9]Grotto I, et al.: Clinical and laboratory presentation of EBV positive infectious mononucleosis in young adults. Epidemiol Infect 2003, 131:683-689.
• [10]Rea TD, et al.: Prospective study of the natural history of infectious mononucleosis caused by Epstein-Barr virus. J Am Board Fam Practice 2001, 14:234-242.
• [11]Gao LW, et al.: Epidemiologic and clinical characteristics of infectious mononucleosis associated with Epstein-Barr virus infection in children in Beijing, China. World J Pediatr 2011, 7:45-49.
• [12]Losa-García JE: Síndrome mononucleósico. Medicine 1998, 7:3813-3817.
• [13]Odumade OA, Hogquist KA, Blafour HH: Progress and problems in understanding and managing primary Epstein-Barr virus infections. Clin Microbiol Rev 2011, 24:193-209.
• [14]Hadinoto V, et al.: On the dynamics of acute EBV infection and the pathogenesis of infectious mononucleosis. Blood 2008, 111:1420-1427.
• [15]Stiki-Green DL, et al.: Biology of Epstein-Barr virus during infectious mononucleosis. J Infect Dis 2004, 189:483-492.
• [16]Bailey RE: Diagnosis and treatment of infectious mononucleosis. Am Fam Physic 1994, 49:879-885.
• [17]Guan-Khoo S, et al.: Spontaneous splenic rupture in infectious mononucleosis. Ear Nose Throat J 2007, 86:300-301.